Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial

British Journal of Surgery

Volumn 99, Issue 2, 2012, Pages 232-237

  Melsen, W G ^a   De Smet, A M G A ^a   Kluytmans, J A J W ^b   Bonten, M J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFOTAXIME; COLISTIN; TOBRAMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS INFECTION; DIGESTIVE SYSTEM DISEASE; DIGESTIVE TRACT INTUBATION; DRUG COMBINATION; FEMALE; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OROPHARYNX; PHARYNX DISEASE; RANDOMIZED CONTROLLED TRIAL; STATISTICS; WASTE MANAGEMENT;

ADMINISTRATION, ORAL; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CEFOTAXIME; CLUSTER ANALYSIS; COLISTIN; CROSS INFECTION; DECONTAMINATION; DIGESTIVE SYSTEM DISEASES; DRUG COMBINATIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; INTUBATION, GASTROINTESTINAL; LENGTH OF STAY; MALE; MIDDLE AGED; OROPHARYNX; PHARYNGEAL DISEASES; RESPIRATION, ARTIFICIAL; TOBRAMYCIN;

EID: 84855702069     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7703     Document Type: Article

References (9)

1. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A,. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316: 1275-1285. (Pubitemid 28181936)
2. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E,. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009; (4)CD000022.
3. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, et al., Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
4. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, et al., Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362: 1011-1016. (Pubitemid 37186877)
5. Krueger WA, Lenhart FP, Neeser G, Ruckdeschel G, Schreckhase H, Eissner HJ, et al., Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002; 166: 1029-1037. (Pubitemid 35178699)
6. Nathens AB, Marshall JC,. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999; 134: 170-176. (Pubitemid 29088969)
7. Bender R, Blettner M,. Calculating the 'number needed to be exposed' with adjustment for confounding variables in epidemiological studies. J Clin Epidemiol 2002; 55: 525-530. (Pubitemid 34462249)
8. Cook RJ, Sackett DL,. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-454.
9. de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, et al., Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011; 11: 372-380.